Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2020
Therapeutic Goods Administration prepare to fast track coronavirus vaccines and treatment
11 March 2020 - The Therapeutic Goods Administration is gearing up to fast track the approval of any vaccines or treatments ...
Posted by Michael Wonder on 09 Mar 2020
Reformatting Product Information: frequently asked questions
6 March 2020 - A new product information form was approved on 8 November 2017, with a commencement date of ...
Posted by Michael Wonder on 04 Mar 2020
International work-sharing initiative - baloxavir marboxil (Xofluza)
5 March 2020 - The Therapeutic Goods Administration (TGA) has approved a new medicine for the treatment of influenza (flu) as ...
Posted by Michael Wonder on 04 Mar 2020
Stop panic buying medicines: pharmacists warn
4 March 2020 - The Pharmacy Guild has warned Australians panic buying of medicines will only make existing supply issues ...
Posted by Michael Wonder on 04 Mar 2020
Anti-flu pill can fight illness as soon as symptoms show
4 February 2020 - A new pill that can fight the flu as soon as symptoms strike has been approved ...
Posted by Michael Wonder on 02 Mar 2020
Coronavirus triggers national medical stockpile as COVID-19 threat intensifies
29 February 2020 - It could be any warehouse in Australia. In fact, you may travel past it every day ...
Posted by Michael Wonder on 26 Feb 2020
Independent review of the reforms to the therapeutic goods advertising framework to commence
26 February 2020 - The independent review of the advertising reforms has now commenced, and is being led by Ms Rosemary ...
Posted by Michael Wonder on 25 Feb 2020
Brexit - implications for therapeutic goods in Australia
25 February 2020 - A transition period is in effect until the end of 2020 while the UK and EU negotiate ...
Posted by Michael Wonder on 19 Feb 2020
Frustration as life-saving EpiPens sit in warehouses, pharmacists out of stock
19 February 2020 - The peak body for Australians with severe allergies is calling on pharmacists to stock up on ...
Posted by Michael Wonder on 12 Feb 2020
Australia's biotech innovations heading offshore, prompting calls for greater funding to bring them to market
11 February 2020 - The demand on the health sector has never been more evident, as the world scrambles to ...
Posted by Michael Wonder on 20 Jan 2020
Fees and charges proposal 2020-21
20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...
Posted by Michael Wonder on 20 Jan 2020
New science strategy prepares regulatory scientists for the future
20 January 2020 - The Health Products Regulation Group in the Department of Health has published a new regulatory science ...
Posted by Michael Wonder on 14 Jan 2020
TGA - 2019 in review
14 January 2020 - According to the TGA, it approved 34 new chemical entities in 2019. ...
Posted by Michael Wonder on 03 Dec 2019
EpiPen Jr
2 December 2019 - Due to the critical nature of the ongoing EpiPen Jr shortage, the TGA is allowing one ...
Posted by Michael Wonder on 25 Nov 2019
Acalabrutinib receives TGA approval for CLL and SLL cancers
25 November 2019 - The Therapeutic Goods Administration has approved the use of acalabrutinib (Calquence) for the treatment of patients ...